IVTEAM
Remove idle PIVC when appropriate – Full Text
"Clinicians should regularly reassess the need for intravenous access and remove idle PIVCs when appropriate to promote patient safety and comfort" Kennis et al (2025).
Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 1-12 of 1017 results.
"Clinicians should regularly reassess the need for intravenous access and remove idle PIVCs when appropriate to promote patient safety and comfort" Kennis et al (2025).
"The first part of the guideline provides general recommendations for vascular access in the resuscitation room in adults, whereas the second part describes specific recommendations and strategies for particular emergency situations" Struck et al (2025).
"There is variable utilisation of central venous catheters across participating acute care cardiology units, though overall they are common vascular access modalities" Rodts et al (2025).
"Our causal DAG provides a structured representation of CLABSI risk factors, which may support the design of clinical trials examining interventions to reduce CVC-related infections" Schults et al (2025).
"All patients successfully self-administered rozanolixizumab; more patients preferred manual push. Efficacy and safety were consistent with the known HCP-administered profile. These results support rozanolixizumab self-administration and manual push administration in patients with gMG" Bril et al (2025).
"The Turkish version of the Questionnaire on Best Practices for Short Peripheral Intravenous Catheter Maintenance demonstrated high reliability, as evidenced by its KR-20 value. The use of this questionnaire enables the identification of knowledge gaps among nursing professionals regarding best practices in short peripheral catheter care" Özbay et al (2025).
"When inserted using modern protocols and technologies, FICCs offer a safe and effective alternative for oncology patients without viable upper-body venous access" Parejo Arrondo et al (2025).
"The risk prediction models for PICC-CLABSI demonstrated strong predictive performance. Future research should carefully address all elements of PROBAST framework during study design phase" Cao et al (2025).
"Pharmacist-led PICCs validation improves patient safety and optimises device use, demonstrating its value and sustainability in clinical practice" Tournayre et al (2025).
"CLABSI can be diagnosed by differential time to positivity (DTP), where central venous line (CVL) blood cultures grow 120 minutes faster than peripheral cultures drawn at the same time. Peripheral cultures cause patient discomfort, risk contamination with skin flora, may cause delays in clinical care, and the overall impact is uncertain. We investigated our institution's paired blood culture practice to assess the utility and clinical impact of peripheral cultures" Prudowsky et al (2025).
"We aimed to perform a systematic review and meta-analysis to assess the efficacy of Cyanoacrylate Glue (CG) use in preventing IV complications at the Emergency Department" Sciorilli et al (2025).
"Complications are grouped into incision-, catheter-, and reservoir-related categories. Incision complications include adhesive dermatitis, suture pseudoinfection, wound dehiscence, and erosion. Catheter issues include arrhythmias, central venous stenosis, fracture, fibrin sheath formation, thrombosis, and migration, each with distinct clinical implications. Reservoir complications such as port flipping and extravasation may interrupt therapy and cause tissue injury" Schutt et al (2025).
